SCM
Stonepine Capital Management Portfolio holdings
AUM
$102M
This Quarter Return
-5.09%
1 Year Return
+40.04%
3 Year Return
+160.28%
5 Year Return
+195.28%
10 Year Return
–
AUM
$220M
AUM Growth
+$220M
(+15%)
Cap. Flow
+$37.6M
Cap. Flow
% of AUM
17.1%
Top 10 Holdings %
Top 10 Hldgs %
81.25%
Holding
35
New
9
Increased
14
Reduced
7
Closed
4
Top Buys
| 1 |
AMYT
Amryt Pharma plc American Depositary Shares
AMYT
|
$36.2M |
| 2 |
Galapagos
GLPG
|
$12.8M |
| 3 |
ADMS
Adamas Pharmaceuticals, Inc.
ADMS
|
$5.99M |
| 4 |
GMDA
Gamida Cell Ltd. Ordinary Shares
GMDA
|
$5.02M |
| 5 |
Ovid Therapeutics
OVID
|
$4.21M |
Top Sells
| 1 |
CHMA
Chiasma, Inc. Common Stock
CHMA
|
$32M |
| 2 |
CFMS
Conformis, Inc. Common Stock
CFMS
|
$8.17M |
| 3 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$3.27M |
| 4 |
Xoma
XOMA
|
$2.39M |
| 5 |
EyePoint Pharmaceuticals
EYPT
|
$2.33M |
Sector Composition
| 1 | Healthcare | 90.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CFMS
26
DELISTED
Conformis, Inc. Common Stock
CFMS
| $648K | 0.29% |
486,982
-6,139,103
| -93% | -$8.17M |
|
|
NBSE
27
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
| $396K | 0.18% |
109,742
+78,672
| +253% | +$284K |
|
28
Immunic
IMUX
$77.1M
| $198K | 0.09% |
+22,409
| New | +$198K |
|
|
CFRX
29
DELISTED
ContraFect Corporation
CFRX
| $139K | 0.06% |
34,413
-32,795
| -49% | -$132K |
|
|
SPNE
30
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $131K | 0.06% |
+8,349
| New | +$131K |
|
31
SCYNEXIS
SCYX
$34.1M
| $34K | 0.02% |
6,327
+6,227
| +6,227% | +$33.5K |
|
32
Corvus Pharmaceuticals
CRVS
$427M
| – | – |
-46,886
| Closed | -$125K |
|
|
ISEE
33
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| – | – |
-517,445
| Closed | -$3.27M |
|
|
AGTC
34
DELISTED
Applied Genetic Technologies Corporation
AGTC
| – | – |
-1,000
| Closed | -$4K |
|
|
CHMA
35
DELISTED
Chiasma, Inc. Common Stock
CHMA
| – | – |
-6,770,000
| Closed | -$32M |
|